Interestingly, MYC gene rearrangements are significantly lower in frequency (3–8%) [35,37], and thus far, BCL2 gene rearrangements have not been reported [35,42] in PCNS DLBCL. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.